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ABSTRACT  Resistance  to  chemotherapeutic  agents  in  neoplastic  cells  is  often 
mediated  by expression  of P-glycoprotein, which functions as a  drng-efflux pump 
for a  broad range of substrates.  We have used a  combination of patch clamp and 
video-imaging techniques  to examine  the  expression  and  drug-efflux function of 
P-glycoprotein  and  to  determine  the  possible  correlation  with  swelling-activated 
chloride channels in drug-sensitive and -resistant cell lines. Two pairs of cell lines 
were used  in  these  experiments:  (a)  control  NIH-3T3 cells  and  a  corresponding 
MDRl-transfectant;  and  (b) control 8226  myeloma cells  and  a  derivative  cell line 
selected for resistance  to chemotherapeutic agents.  Control cells lacked detectable 
P-glycoprotein expression based on Western blotting, immunofluorescence staining 
with  a  specific  monoclonal  antibody,  and  a  functional  assay  of rhodamine-123 
(R123)  efflux.  Resistant  cells  expressed  P-glycoprotein at  high  levels and  rapidly 
exported  R123.  During  whole-cell  recording  using  either  hyperosmotic  pipette 
solution  or  hypoosmotic  Ringer  solution,  cell  swelling  was  accompanied  by  C1- 
channel opening in all four cell lines. The rates of induction, biophysical properties 
and  magnitudes  of Cl-  conductance  (gc1) were  indistinguishable  between  control 
and corresponding multidrug-resistant cells: gcl reached 0.96  _+ 0.31  (n =  14) and 
0.83  -  0.31  nS/pF  (mean -+ SD; n  =  31)  in  NIH-3T3 and  NIH-3T3/MDR cells, 
respectively; and 0.31  +  0.20 (n =  9) and 0.37  +  0.22 nS/pF (n -- 7) in 8226 and 
8226/Dox40  cells,  respectively,  gcl  exhibited  moderate  outward  rectification  in 
symmetrical Cl- solutions, with a rectification ratio of 1.4 at -+ 50 mV. C1- channels 
slowly  closed during strong depolarization beyond  +60 mV.  Using video-imaging 
techniques with SPQ as a fluorescent probe, we monitored C1--channel opening in 
intact  drug-sensitive  and  -resistant  cells,  gcb  measured  either  with  whole-cell 
recording or SPQ imaging, was blocked by DIDS (voltage-dependent Kd <  50  p~M 
at +40 mV), NPPB (Ka  ~  30 ~M), and tamoxifen (complete and irreversible block 
~ 10 IzM).  None of these blockers inhibited  R123 effiux.  NPPB accelerated  R123 
efflux,  an  effect  that  was  mimicked  by  CCCP,  a  mitochondrial  uncoupler.  In 
contrast, verapamil selectively blocked R123 efflux (Kd =  0.3 to 0.5 I~M); 10 p~M left 
gcl unaltered.  Induction ofgcl was not affected by vincristine or doxorubicin in the 
pipette  solution.  Moreover,  the  rate  of R123  efflux  did  not  change  during  cell 
swelling. We conclude that P-glycoprotein and swelling-activated chloride channels 
function independently  and  are  separable  by expression  and  by pharmacological 
sensitivities. 
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INTRODUCTION 
When  exposed  to  changes  in  extracellular  osmolarity,  many  mammalian  cells 
regulate their volume by coupling water flux to osmolyte transport across  the cell 
membrane. K  + and CI- currents contribute a large fraction of the total osmolyte flux 
(Hoffmann and Simonsen, 1989). In particular, swelling-activated  CI- channels may 
be  important  in  triggering  and  maintaining the  ionic  flux  required  for volume 
regulation (Cahalan and Lewis, 1988, 1994). Although only cells within the kidney or 
digestive tract are likely to experience large changes in osmolarity, swelling-activated 
CI- channels are found in many epithelia and other tissues. Thus, swelling-activated 
C1-  channels may serve  alternative functions such  as  epithelial fluid transport or 
volume regulation during cell division or motility. 
The molecular characterization of CI-  channels provides  significant  insight into 
their structure and function. Unlike the families of homologous proteins that form 
K  +,  Ca  2+,  and Na + channels, there is a wide  diversity  of molecules that form C1- 
channels (for review, see Frizzell and Cliff, 1992). Without highly conserved structural 
motifs to distinguish potential channel-forming molecules,  and because there are no 
specific toxins or potent pharmacological agents to aid in their identification, each 
candidate C1- channel must be carefully evaluated for function and expression. Such 
a  detailed  analysis,  including  biophysical,  biochemical,  and  molecular  biological 
characterization, has been performed on the cystic fibrosis transmembrane conduc- 
tance regulator (CFFR), indicating that the CFTR can form one type of CI- channel 
(reviewed  by  Welsh,  Anderson,  Rich,  Berger,  Denning,  Ostedgaard,  Sheppard, 
Cheng, Gregory, and Smith,  1992). 
The  CFFR belongs  to  the  ABC  (ATP-binding  cassette)  superfamily.  A  second 
member  of  this  family,  P-glycoproteinwthe  MDRI  gene  product,  is  an  ATP- 
dependent transporter responsible for multidrug resistance to a broad spectrum of 
chemotherapeutic agents (Higgins,  1992; Gottesman and Pastan,  1993). P-glycopro- 
tein is endogenously expressed in several epithelial tissues, which may also express 
swelling-activated  C1-  channels (Hitchins,  Harman,  Davey, and Bell, 1988; Arceci, 
Baas,  Raponi,  Horwitz,  Housman,  and  Croop,  1990; van  Kalken,  van  der  Valk, 
Hadisaputro, Pieters,  Broxterman, Kuiper, Scheffer, Veerman, Meyer, and Scheper, 
1991; van Kalken,  Giaccone,  van der Valk,  Kuiper, Hadisaputro, Bosma,  Scheper, 
Meijer,  and Pinedo,  1992; Toth, Vaughan, Slocum, Arredondo, Takita, Baker,  and 
Rustum, 1994). Valverde and co-workers (1992), based on evidence that transfection 
of the MDR1  gene into NIH-3T3 fibroblasts  or into S1 lung carcinoma cells resulted 
in  the  expression  of  both  P-glycoprotein  and  swelling-activated  C1-  channels, 
suggested that P-glycoprotein has two distinct functions: an ATP hydrolysis-depen- 
dent drug-transport pump  or  a  swelling-activated  CI-  channel that requires ATP 
binding, but not hydrolysis. In their model (Gill, Hyde, Higgins, Valverde,  Mintenig, 
and Sepulveda,  1992), cell swelling traps P-glycoprotein in its CI- channel conforma- 
tion,  thus  making  it  unavailable  to  pump  drugs.  Conversely,  drug  binding  and 
transport traps P-glycoprotein in its pump conformation, preventing the induction of 
its C1- conductance (go) by subsequent cell swelling. 
Recently,  however,  several  studies have  indicated a  lack  of correlation between 
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P-glycoprotein,  showed  similar  rates  of transepithelial  secretion  of vinblastine,  an 
antineoplastic agent, whether or not they exhibited gcJ (McEwan, Hunter, Hirst, and 
Simmons,  1992). Rasola, Galietta, Gruenert, and Romeo, (1994), using epithelial cell 
lines  selected  for  drug  resistance,  found  no  correlation  between  P-glycoprotein 
expression and gcl. In addition, hypoosmotic stress did not affect the accumulation of 
rhodamine-123 (R123), a substrate for P-glycoprotein transport, in mouse lymphoma 
cells transduced with the MDR1  gene (Weaver, Szabo, Pine, Gottesman, Goldenberg, 
and Aszalos,  1993). Altenberg, Vanoye, Han, Deitmer, and Reuss (1994b) found that 
multidrug-resistant  Chinese  hamster  fibroblasts,  which  express  high  levels  of P- 
glycoprotein,  did  not  express  swelling-activated  CI-  channels.  However, they  also 
observed gcl in human breast cancer cells (BC19/3) rendered multidrug-resistant by 
transfection with  the  human  MDR1  gene;  such currents were not  observed in  the 
parental drug-sensitive cell line (MCF-7).  Interestingly, neither BC19/3 nor MCF-7 
cells volume-regulate or permit measurable amounts of CI- efflux under hypoosmotic 
stress (Altenberg, Deitmer, Glass, and Reuss,  1994a). 
We  have  further  tested  the  hypothesis  of Valverde  et  al.  (1992)  that  swelling- 
activated  chloride  currents  are  associated  with  increased  expression  of  human 
P-glycoprotein  after  (a)  transfection  with  the  MDR1  gene  or  (b)  selection  for 
multidrug resistance.  Four cell lines were evaluated for both chloride conductance 
and  P-glycoprotein-mediated substrate  efflux:  (a)  the  drug-sensitive  8226  human 
myeloma cell line; (b) its drug-resistant derivative line, 8226/Dox40 (Dalton, Grogan, 
Rybski, Scheper, Richter, Kailey, Broxterman, Pinedo, and Salmon,  1989); (c) control 
NIH-3T3  mouse fibroblasts;  and  (d)  NIH-3T3/MDR  cells permanently transfected 
with the human MDR1  gene (Ueda, Cardarelli, Gottesman, and Pastan,  1987; Kioka, 
Tsubota,  Kakehi,  Komano,  Gottesman,  Pastan,  and  Ueda,  1989;  Bruggemann, 
Currier,  Gottesman,  and  Pastan,  1992).  Initially,  we  measured  gcJ  induced  by 
osmotically driven cell swelling, using conventional whole-cell recording. In addition, 
we used video-imaging techniques to monitor both  P-glycoprotein substrate  efflux 
and swelling-activated chloride conductance in intact cells. We show that P-glycopro- 
tein-mediated drug efflux and swelling-activated chloride conductance are separable 
functions, both  pharmacologically and  by mode of activation.  Our results  indicate 
that  there  is  no  correlation between  P-glycoprotein and  C1-  channel  expression. 
These  results  have  been  presented  in  preliminary  form  (Ehring,  Osipchuk,  and 
Cahalan,  1994; Osipchuk,  Ehring, and Cahalan,  1994). 
MATERIALS  AND  METHODS 
Cells 
The drug-sensitive  8226  myeloma cell line and the drug-resistant  8226/Dox40 cell line were 
obtained from Dr. William Dalton (Arizona Cancer Center, University of Arizona, Tuscon, AZ). 
Both cell lines were cultured in suspension  at 37~  in 5% CO~ and maintained in RPMI 1640 
medium  containing  25  mM  N-hydroxyethylpiperazine-N'-2-ethanesulfonic  acid  (HEPES) 
supplemented with  10% fetal bovine  serum (FBS), 1% penicillin  streptomycin (P-S) and  1% 
L-glutamine. 8226/Dox40 cells were also treated with 4 x  10  -7 M doxorubicin every two weeks. 
These cells were fed twice weekly and split weekly. For patch clamp experiments, the cells were 
plated on glass coverslips which had been pretreated with 1 mg/ml poly-L-lysine. 
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of MDRI  were  obtained from Dr.  Michael Gottesmann (National Cancer Institute, National 
Institutes of Health, Bethesda, MD). Both lines were cultured as monolayers at 37~  in 5% COe 
using DMEM containing 25 mM HEPES and supplemented with 4.5 g glucose per liter, 10% 
FBS, 1% P-S and 1% L-glutamine. The medium for the MDR1  transfectant was supplemented 
with  60  ng/ml colchicine. We  confirmed the  increased expression of P-glycoprotein in the 
drug-resistant lines by immunoblotting. Membrane preparations from all four cell lines were 
run on SDS-PAGE gels,  immunoblotted, and stained by an antibody (C219)  to a cytoplasmic 
carboxy-terminal epitope of P-glycoprotein (Georges,  Bradley, Gariepy, and Ling, 1990). 
Solutions  and Reagents 
For  most  of  the  patch-clamp  experiments,  the  cells  were  bathed  in  mammalian Ringer 
containing (in millimolar): 160  NaC1, 4.5  KC1, 2 CaCl 2,  1 MgCI2, 0.1  BaCI and  10 HEPES, 
adjusted to pH 7.4 with NaOH and having an osmolarity of 310 mosm. Hypoosmotic Ringer 
(67%  Ringer)  was  prepared  by  diluting mammalian Ringer with  deionized  (MilliQ)  H20 
(Millipore Corp.,  Milford,  MA). Pipette  (internal) solutions contained  160  Cs  aspartate,  2 
MgCI2,  5  HEPES,  and  10  ethylene glycol-bis  ([3-aminoethylether)  N,N,N',N'-tetraacetic  acid 
(EGTA),  pH  adjusted  to  7.2  with  KOH;  310  mosm.  Hyperosmotic  internal solution was 
prepared by adding 100 mM sucrose to the pipette solution. In some experiments, the cells 
were  patch  clamped  with  a  pipette  solution containing (in  millimolar):  140  N-methyl-D- 
glucamine chloride (NMG-CI), 1.2 MgCI~, 1 mM EGTA and 10 mM HEPES with 2 mM NaATP 
adjusted  to  pH  7.4  (310  mosm).  In  these  experiments,  the  cells  were  initially bathed  in 
isoosmotic NMG-CI Ringer containing (in millimolar): 140 NMG-C1, 1.3 mM CaC12, 0.5 MgCI2 
and 10 mM HEPES (pH 7.4,  310 mosm). Hypoosmotic (70%) Ringer was made by reducing 
NMGCI to 105 mM. Osmolarity was measured with a vapor pressure osmometer (Wescor Inc., 
Logan, UT). Bath solutions were exchanged by perfusing the chamber ( ~ 250 ~1 vol) with 2-5 
ml of the  test  solution. Exchange was  complete in  < 30  s.  Chloride was replaced by either 
iodide or nitrate for video-imaging measurements of chloride conductance. Iodide solution: 
135  Nal,  2.4 KzHPO4, 0.6  KH2PO4,  1 MgSO4, 1 CaSO  4,  10 HEPES  (pH  7.4,  adjusted with 
NaOH).  Nitrate  solution:  135  NaNO3,  2.4  K2HPO4, 0.6  KH2PO4,  1  MgSO4,  1 CaSO4, 10 
HEPES  (pH  7.4,  adjusted  with  NaOH).  Normal  osmolarity was  adjusted  to  310  mosm. 
Hypoosmotic solutions (50-90% of normal osmolarity) were prepared by diluting solutions with 
MiiliQ water. 
Most salts and reagents (reagent grade or better) were obtained from Sigma Chemical Co. 
(St. Louis,  MO).  Doxorubicin, vincristine and verapamil were obtained from Sigma Chemical 
Co. and 5-nitro-2-(3-phenylpropylamino)  benzoic acid (NPPB) from Biomol Research Labora- 
tories,  Inc. (Philadelphia, PA). Rhodamine-123 (R123), 6-methoxy-N-(sulfopropyl)quinolinium 
(SPQ)  and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic  acid  (DIDS) were  obtained from  Mo- 
lecular Probes, Inc. (Eugene, OR). All drugs were dissolved in DMSO at a stock concentration 
at least 1,000 times greater than the final bath concentration. 
The 4E3 monoclonal IgG antibody specific to an extracellular epitope on P-glycoprotein, and 
C219 monoclonal antibody to an intracellular epitope on P-glycoprotein were obtained from 
Signet Laboratories (Dedham, MA). FITC-conjugated and Texas red-conjugated goat F(ab')2 
anti-mouse IgG were obtained from Caltag Laboratories (South San Francisco, CA). 
Flow Cytometry 
Aliquots of ~ l  ￿  106 cells were taken directly from 8226 myeloma or 8226/Dox40  suspension 
cultures, or after trypsinization of NIH-3T3 control and NIH-3T3/MDR cell-adherent cultures, 
and resuspended in 100 ~1 phosphate buffered saline supplemented with 0.1% fetal calf serum 
(PBS/FCS).  Primary antibodies (0.5  p.g), either isotypic  control IgG or monoclonai 4E3,  were 
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temperature. Unbound primary antibody was removed by dilution into 1 ml PBS/FCS followed 
by centrifugation at 300 g  for 5 min. The wash  procedure was repeated twice and the cells 
resuspended in 100 ~1 PBS/FCS containing ~ 0.5 ~g FITC-conjugated  goat F(ab')2 anti-mouse 
IgG.  The  cells  were  vortexed  for  3-5  s  and  incubated in  the  dark  for  25  rain  at  room 
temperature. Unbound F(ab')2 fragments were removed as described for the primary antibody. 
Cell fluorescence was measured on a  FACScan  |  flow cytometer (Becton Dickinson, Mountain 
View, CA). FITC fluorescence was excited by 150 mW of 488-nm light from an argon laser, and 
the emitted light was passed to a photomultiplier tube through a 530 +  15 nM band pass filter 
(FL-1). Frequency histograms of the logarithm of the fluorescence were calculated for  ~ 5,000 
cells from each cell line using LYSIS II software  (Becton Dickinson). 
Confocal Microscopy 
To  measure  protein  expression  and  functional drug  transport,  cells  were  simultaneously 
labeled  for  P-glycoprotein  expression  with  4E3  antibody  and  incubated  with  R123.  In 
drug-sensitive cells,  R123 diffuses  across  the cell membrane, enters the cytoplasm and gets 
trapped  within  the  mitochondria  because  of  the  mitochondrial  membrane  potential.  In 
drug-resistant cells, the P-glycoprotein pump keeps the cytoplasmic concentration of R123 low 
and prevents accumulation within mitochondria. For these experiments, cells were adhered to 
glass coverslips  in normal culture medium overnight in the incubator. The following day, cells 
were washed with mammalian Ringer then incubated at room temperature for 1.5 h with 5 I~M 
R123  in Ringer  -  10  ~M  verapamil. During the  first half hour of incubation, the  Ringer 
solution also contained 4E3 antibody. The cells were then washed two times with fresh Ringer 
containing  5 ~M R 123. During the last half hour of R 123 incubation, the cells were labeled with 
Texas red-conjugated goat F(ab')2 anti-mouse IgG. Treated cells were placed on the confocal 
microscope and washed twice with normal medium. 
The confocal microscope system consisted of a Nikon Labophot upright microscope with a 
Bio-Rad MRC-600 confocal laser scanner equipped with a krypton/argon laser (Bio-Rad Co., 
Hercules, CA). The light path included selectable excitation filters at 488 or 568 nm, a double 
dichroic mirror with  near total  reflectance for wavelengths of 488  and  568  nM  and  high 
transmission of wavelengths between 500 and 550 nm or wavelengths  > 600 nm. Texas red 
emission was measured, after excitation at 568 nm, as the intensity of light transmitted through 
a  second dichroic mirror (> 560  nm) and through a  585-nm long-pass emission filter to  a 
photomultiplier tube (PMT1).  R123 emission was measured, following excitation at 488 nm, as 
the light reflected by the second dichroic mirror (< 560 nm) and passing through a 522-nm 
band pass filter to a second photomultiplier tube (PMT2).  Because of the wide band widths for 
both  emission and  excitation  of  R123,  the  fluorescence  for  the  double-labeled cells  was 
measured in two  sequential images. The first  image was  taken using 488-nm excitation to 
collect R123  (green) fluorescence, and the second used 568-nm excitation to collect Texas red 
(red) fluorescence. This procedure eliminated spectral overlap between the two dyes. Transmit- 
ted light images were  taken by replacing the filter cube for PMT2 with a  fiber optic which 
collected the light passing directly through the specimen. 
Patch Clamp Recording 
Experiments were  carried out using standard whole-cell patch  clamp recording techniques 
(Lewis, Ross, and Cahalan, 1993). All experiments were done at room temperature (22-26~ 
Patch pipettes were pulled from Accu-fill 90 Micropets (Becton, Dickinson, and Co.,  Parsip- 
pany, NJ) coated with Sylgard (Dow Coming Corp., Midland, MI) to within 50-100 g.m of their 
tips, and fire polished to resistances between 1.2 and 3.0 MI'~  when filled with internal solution 
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between the recording pipette and the bath solution. The pipette current was hulled before seal 
formation  (Neher,  1992).  Cell  membrane  and  pipette  capacitance  were  canceled  using 
electronic feedback via the patch clamp amplifier (AxoPatch  l-D, Axon Instruments Inc., Foster 
City, CA). A PDP-I 1/73 computer and interface running programs written in BASIC-23 were 
used  to  generate voltage commands and digitize and  analyze patch  clamp current output 
(Indec  Systems  Inc.,  Sunnyvale, CA). Pipette  access  resistance  and  cell  capacitance  were 
measured by analyzing the current in response to a 5-ms, 20-mV test pulse. The capacitative 
current  transient recorded  immediately after  break  in was  fitted  to  a  single  exponential 
function to  determine resting membrane capacitance (Cm), and initial access  resistance,  R a 
(Lindau and Neher,  1988). Cells were selected for study if initial Ra was  < 10 MfI.  Cm and Ra 
were monitored throughout the experiment; ifRa increased more than twofold, the experiment 
was terminated and data from that cell excluded. The holding potential for all experiments was 
-60 mV. Membrane currents were measured in response to 200-ms voltage ramps from -100 
to 50 mV, or 200-ms voltage pulses from the holding potential in 20-mV increments from -  100 
to + 100 mV. Grouped data are presented as mean -  SD. When appropriate, the difference 
between two means was statistically  tested by a two-tailed t test. 
Video Microfluorescence Measurements 
NIH-3T3 cells or NIH-3T3/MDR cells grown on glass coverslips were placed on the stage of an 
inverted microscope (Zeiss Axiovert 35).  8226 or 8226/Dox40  cells grown in suspension were 
seeded onto glass coverslips coated with poly-L-lysine (Sigma Chemical Co.). A 75 W Xenon arc 
lamp  (Osram  XBO-75),  powered  by  a  stable  power  supply  (Model  1500,  Opti-Quip  Inc., 
Highland Mills,  NY), was  used  as  a  light  source.  Excitation light was  passed  through  an 
interference filter (470 nm, band width 20 nm for R123; and 340 nm, band width  10 nm for 
SPQ) and reflected by a dichroic mirror (cut-offwave lengths 505 and 400 nm, respectively,  for 
R123 and SPQ) through a 60x plan-neofluar  objective. Epifluorescence images were filtered by 
a barrier filter with cut-offwavelength 520/400 nm (RI23/SPQ) and collected by an intensified 
CCD video camera (Hamamatsu, C2400).  Images were digitized and averaged (8-16 frames), 
background-corrected,  stored  every  3-10  s,  and  analyzed by  an  image-processing system 
(VideoProbe,  ETM Systems, Irvine, CA). Filters and dichroic mirrors were from Omega Optical 
(Brattleboro, VT). Fluorescence intensities of individual cells in the field of view (up to 512 per 
field)  were  determined by averaging the  image  intensity collected from  regions of interest 
within each cell. 
Imaging Plasma Membrane Chloride Conductance 
Cells were loaded with SPQ by incubation in medium containing 10 mM SPQ for 2-6 h at 37~ 
The intracellular SPQ concentration was  ~ 100  IzM. The fluorescence intensity of entrapped 
intracellular SPQ was used as a measure of halide concentration. Quenching of SPQ fluores- 
cence by intracellular halides was determined according to the Stern-Volmer equation: 
F = Fo/(1  + K[Hal-]). 
Fo  and  F  are  the  SPQ  fluorescence in  the  absence  and  presence  of halide;  [Hal-]  the 
concentration of halide; and K a quench constant. K is equal to 118 M  -1 for CI-, 276 M -l for 
I-, and is negligibly low for NO~- (Illsley and Verkman,  1987).  Cells  loaded with SPQ were 
incubated in external solution containing I- for 20 min to quench intraceilular SPQ fluores- 
cence. When NO~  was  exchanged for  I-  in the  extracellular solution, intraceUular I-  ions 
escaped the cell through chloride channels and were replaced by NO~, effectively unquenching 
SPQ and thereby increasing SPQ fluorescence. The rate of replacement and, hence, fluores- 
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study the time course of the chloride conductance, extracellular solution was toggled between 
solutions containing the permeant anions I- and NO~, with a period of exchange ranging from 
50 to 100 s. Solution flow was propelled by 10-psi air pressure from a multibarrel tube into the 
experimental chamber and controlled through electromagnetic valves (General Valve, Fairfield, 
NJ) by VideoProbe software.  Solution exchange in the 200-1zl chamber was complete within 
< 10  s.  Repetitive  exchange of anions in extracellular  solution led to repetitive  exponential 
decreases and increases of intracellular SPQ fluorescence as I- and NO~ ions moved in and out 
of the cells through chloride channels. Thus, the rate of fluorescence increase and decrease was 
proportional to the plasma membrane chloride conductance. 
Imaging P-Glycoprotein  Substrate  Efftux 
As  a  substrate  for extrusion  by the  drug-efflux  pump,  R123  is  particularly  well  suited  for 
functional  investigation  of P-glycoprotein  (Neyfakh,  1988;  Lampidis,  Castello,  del  Giglio, 
Pressman, Viallet,  Trevorrow, Valet,  Tapiero, and Savaraj,  1989;  Kessel,  Beck,  Kukuruga, and 
Schulz,  1991; Weaver, Pine, Aszalos, Schoenlein, Currier, Padmanabhan, and Gottesman, 1991; 
Ludescher, Thaler, Drach, Drach, Spitaler, Gattringer, Huber, and Hofmann, 1992; Altenberg 
et al.,  1994b). Cells were loaded with R123 by incubation in medium containing 5 IzM R123 for 
20 min at room temperature. For drug-resistant cells (NIH-3T3/MDR and 8226/Dox40),  5 ~M 
verapamil was also added to block P-glycoprotein-mediated efflux of R123. After wash out of 
extracellular R123, the final  concentration of R123 in the cells was measured by lysing  ~ 106 
cells in 200 Izl Ringer containing 1% Triton X-100 and comparing the fluorescence intensity of 
the lysate with  standard  concentrations of R123.  The  average intracellular concentration of 
R123 was  ~ 50 IxM. External dye was washed out by rinsing the cells with  > 10￿  excess Ringer. 
R123 efflux was assayed by the decrease in fluorescence intensity of individual cells, and fitted 
with a single exponential function using Igor software (WaveMetrics,  OR) run on a Macintosh 
(Apple Computer, Sunnyvale, CA). 
RESULTS 
Results are presented below in four main sections: first, a determination of molecular 
and  functional  expression  of  P-glycoprotein;  second,  patch  clamp  experiments 
demonstrating  CI- channel opening during osmotically induced cell  swelling;  third, 
SPQ fluorescence measurements  of chloride conductance in intact cells; and fourth, 
measurements  of R123 effiux mediated by the P-glycoprotein drug-efflux pump. 
Cell Phenotype 
We  determined  the  increased  expression  of P-glycoprotein  using  flow  cytometry, 
immunofluorescence,  and  Western  blotting.  For  flow-cytometric  analysis,  we  used 
monoclonal  4E3  (Arceci,  Stieglitz,  Bras,  Schinkel,  Baas,  and  Croop,  1993)  and  a 
secondary  antibody  conjugated  to  FITC.  Control  NIH-3T3  mouse  fibroblasts  (Fig. 
1 A)  and  drug-sensitive  8226  myeloma  cells  (Fig.  1 C)  had  identical  levels  of 
fluorescence when  stained  with  P-glycoprotein-specific 4E3  antibody  or an  isotypic 
control. No P-glycoprotein expression was measurable in these cell lines. In contrast, 
compared  to  control,  fluorescent  staining  was  >  132-fold  greater  in MDRl-trans- 
fected NIH-3T3 fibroblasts  (Fig.  1 B) and  > 85-fold greater in drug-resistant  8226/ 
Dox40  cells  (Fig.  1 D)  after  staining  with  4E3.  Membranes  from  8226/Dox40  and 
NIH-3T3/MDR  cells  contained  a  ~170  kD  protein  which  was  recognized  by 
monoclonal C219. This protein was not detected in the 8226 myeloma or NIH-3T3 1136  THE JOURNAL OF GENERAL PHYSIOLOGY ￿9 VOLUME 104 ￿9 1994 
control cell  membranes.  These  data confirm previously published  observations  that 
P-glycoprotein was not detectable  in the  drug-sensitive  cell lines,  but  gave a  strong 
signal  in  the  drug-resistant  cell  lines when  analyzed by immunoblot  (Dalton  et  al., 
1989;  Tanaka,  Currier,  Bruggemann,  Ueda,  Germann,  Pastan,  and  Gottesman, 
1990).  Thus,  by two different criteria,  the  drug-resistant  cells  showed high levels of 
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FIGURE  1.  P-glycoprotein expression determined by flow cytometry. Indirect immunofluores- 
ence from cells labeled with FITC-conjugated secondary F(ab')2 fragments after incubation with 
an isotypic control antibody (dotted lines)  or a P-glycoprotein-specific monoclonal antibody (4E3; 
solid lines).  Drug-sensitive lines NIH-3T3 (A) and 8226 myeloma (C) and drug-resistant lines 
NIH-3T3/MDR (B) and 8226/Dox40 (D). Histograms plotting the number of ceils against the 
log of the measured fluorescence show that drug-sensitive cells were equally fluorescent when 
labeled with control or 4E3 antibodies.  In contrast, drug-resistant cells were  ~ 100-fold more 
fluorescent after labeling with 4E3 compared with control. The shift  in fluorescence seen for 
NIH-3T3/MDR cells corresponds to  ~ 100,000 4E3 antibody-binding sites at the cell surface, 
according to a calibration performed with standardized fluorescent beads. 
P-glycoprotein expression, while the drug-sensitive cells failed to produce measurable 
quantities. 
To confirm that drug efflux was associated with P-glycoprotein expression in these 
cells,  we  performed  dual-fluorescence  measurements  using  a  confocal microscope. 
R123 is a substrate for the MDRl-encoded  drug-efflux pump (Lampidis et al.,  1985; 
Neyfakh,  1988;  Kessel  et  al.,  1991)  and  mitochondrial  accumulation  of R123  has EHRrNc ET AL.  MDR and Chloride Channels  1137 
been  shown  to  be  inversely correlated with  multidrug  resistance  (Neyfakh,  1988; 
Ludescher et al.,  1992). We incubated drug-resistant and drug-sensitive cell lines in 5 
I~M R123 in the presence or absence of 10 I~M verapamil (Fig. 2). Verapamil reverses 
multidrug  resistance  by  inhibiting  drug  effiux  (Tsuruo,  Iida,  Tsukagoshi,  and 
Sakurai,  1981; Tsuruo,  Iida,  Naganuma,  Tsukagoshi,  and  Sakurai,  1983).  Indirect 
immunofluorescence  with  4E3  antibody  was  used  to  test  for  expression  of  P- 
FIGURE 2.  P-glycoprotein  expression correlates with  R123  transport.  NIH-3T3 cells  (A-C) 
and NIH-3T3/MDR cells (D-I) in nonconfocal,  transmitted light images (A,D,G); in confocal 
fluorescence  images  showing P-glycoprotein  expression by immunofluorescence (B,E,H); and 
in confocal fluorescence  images showing R123 accumulation  (C,F,I). Only the NIH-3T3/MDR 
cells (E,H)  were  labeled  by  the  anti-P-glycoprotein  monoclonal  antibody.  NIH-3T3  cells 
accumulated intracellular  R123  after 1.5 h  incubation (C). Punctate staining  indicates  mito- 
chondrial localization of R123. No dye accumulated  in NIH-3T3/MDR cells incubated in 5 I~M 
R123 alone (F); however, after incubation in 5  I~M R123 plus  10 I~M verapamil,  NIH-3T3/ 
MDR cells showed mitochondrial accumulation  of R123 (I) identical  to the NIH-3T3 control 
cells (C). 
glycoprotein during these experiments. As  expected from the FACS  |  experiments, 
the  drug-sensitive  NIH-3T3  control cells were  not  labeled  by 4E3  (Fig.  2 B),  but 
instead  showed  punctate  staining  with  R123  (Fig.  2  C),  indicating  mitochondrial 
localization.  In  contrast,  NIH-3T3/MDR cell membranes were distinctly labeled by 
4E3, but the cells did not accumulate R123 (Fig. 2, E-F). When N1H-3T3/MDR cells 
were  incubated  with  R123  plus  10  I~M  verapamil,  both  membrane  staining  for 
P-glycoprotein ,and  mitochondrial staining with  R123 were observed. (Fig.  2,  H-I). 1138  THE JOURNAL OF GENERAL PHYSIOLOGY "  VOLUME 104  ￿9 1994 
Blocking  the  transport  function  allowed  R123  to  enter  drug-resistant  cells  and 
accumulate  in  the  mitochondria,  as  seen  in  drug-sensitive  cell  lines.  Similar  results 
were  obtained  using  this  labeling  protocol  on  8226  myeloma and  8226/Dox40  cells 
(data  not  shown).  Thus,  drug-sensitive  and  drug-resistant  cell  lines  differ  both  in 
expression  of P-glycoprotein  and their ability to pump R123. 
Induction  of gct in Drug-sensitive and -resistant Cell Lines 
In  contrast  to  P-glycoprotein  expression  and  drug  transport,  we  observed  no 
difference  in  the currents  elicited  by osmotic  challenge  between  drug-sensitive  and 
drug-resistant  cell lines.  Cell dialysis with hyperosmotic pipette  solution (400 mosm) 
during  whole-cell  patch  clamp  experiments  caused  a  gradual  induction  of an  out- 
wardly rectifying  current  for  all  four cell  lines  (Fig.  3).  Two experiments  identified 
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FIGURE 3.  Drug-sensitive  and  drug-resistant  cell  lines  express  similar  gcl.  Dialysis  with 
hyperosmotic cesium aspartate internal  solution induced outwardly  rectifying C1-  currents  in 
8226-myeloma  (A),  8226/Dox40  (B),  NIH-3T3  (C)  and NIH-3T3/MDR  (D)  cells.  Whole-cell 
currents  were elicited  by 200-ms voltage ramps from  -100  to  +50 mV. An initial  ramp was 
taken immediately  after  break in and ramps continued  at  5-s intervals  during dialysis.  Time 
elapsed in seconds since break in is indicated next to each trace. 
this current as a  chloride  current.  First,  when  the pipette  solution contained  cesium 
and aspartate as the principal  ions and the bathing  solution was mammalian  Ringer, 
the reversal  potential  for the current was  ~  -45  mV. When most of the  Ringer  CI- 
was  replaced  by  aspartate,  the  outward  current  was  reduced  and  the  reversal 
potential  shifted  to  0  mV,  as  expected  for  a  chloride-selective  channel  (data  not 
shown).  Second,  when  the  swelling-activated  current  was  induced  in  solutions  with EHRIN6 ET ,~.  MDR and Chloride Channels  1139 
equivalent intracellular and  extracellular C1-  concentrations, the reversal potential 
was near 0 mV (see Fig. 8 below). 
Using  voltage-ramp  stimuli,  we  determined  the  time  course  of  CI-  current 
induction  by  calculating  the  slope  conductance  near  the  reversal  potential  after 
establishing  the  whole-cell  patch  clamp  configuration  (break  in)  (Fig.  3).  When 
currents were induced by hyperosmotic pipette solution, the conductance remained 
relatively constant at  < 1 nS for ~ 50 s and then increased over the next 200-300 s to 
a  plateau  (Fig.  4).  There was  no significant difference between drug-sensitive and 
-resistant cell lines in the maximum conductance, the rate of induction ofgcb or the 
reversal potential (Table I, Fig. 4). In general, the currents elicited in both NIH-3T3 
fibroblast cell lines were  larger  than  those  of the  paired  myeloma cell lines.  This 
difference is accounted for, in part, by the larger size of NIH-3T3 cells as measured 
by their membrane capacitance (Table I). 
Identical  CI-  currents were  induced  by  using  isoosmotic pipette  solutions  (310 
mosm)  and  challenging  the  cells with  hypoosmotic external  solutions  (210  mosm) 
(Table  I).  As  with  the  hyperosmotic  stimulus,  there  was  no  difference  in  the 
maximum  conductance,  the  rate  of induction  of gcb  or  the  reversal  potential, 
comparing drug-sensitive with  the  corresponding drug-resistant  cell line  (Table I, 
Fig. 3). We also tested NMG-CI solutions used in previous studies (Gill et al.,  1992; 
Valverde et al.,  1992), but found no difference in gcl obtained in drug-sensitive or 
-resistant cells. The rectification ratio (Ic1,+50  mV/Icl,-50 mV) of the current in NMG-C1 
solutions was  1.45 -+ 0.04 (n =  3) for NIH-3T3 control cells and  1.46 -+ 0.16 (n =  8) 
for  NIH-3T3/MDR  cells.  These  results  suggest  that  the  C1-  channel  has  similar 
induction and permeation properties in both cell types. 
Once  induced,  the  outwardly rectifying CI-  current was  nearly constant  during 
200-ms voltage pulses from -100 to + 100 mV, with no evidence of time-dependent 
channel opening or closing (Fig. 5). The current amplitudes recorded during voltage 
steps overlay those during voltage ramps, suggesting that outward rectification is due 
to permeation properties rather than voltage- or time-dependent gating.  Channels 
slowly  closed during prolonged depolarization with a  time course that varied from 
cell to cell.  During  200-ms  pulses  to voltages positive to  +120  mV or during  10-s 
pulses to voltages positive to  +60 mV, a  slow relaxation indicating channel closure 
can be seen in Fig. 5. Thus, the biophysical properties of gcl did not differ between 
drug-sensitive and -resistant cells. 
Pharmacology. The proposed link between P-glycoprotein expression and gel was 
based, in part, on the argument that agents which block drug transport can also block 
gcl- For example, Valverde et al. (1992) showed that  100 ~M verapamil, a dose that 
reverses multidrug resistance and prevents drug transport, decreased gcl in MDR1- 
transfected NIH-3T3 fibroblasts. 
We  have  shown  that  10  ~M verapamil completely blocks the  transport  of R123 
from  8226/Dox40  cells  and  NIH-3T3/MDR  cells  (see  Fig.  12  below);  the  Kd  for 
verapamil block is 0.3 to 0.5 ~M. However, as illustrated in Fig. 6,  10 CM verapamil 
had  no effect on gcl in NIH-3T3 control or NIH-3T3/MDR cells.  Higher doses of 
verapamil (100  ~M) reduced gcz to 70  -  15% (n =  3) of control. The significantly 
higher concentrations required  to block gel  suggest  that  this  effect results  from a 
different mechanism than the block of the MDR pump. In Contrast, 50 ~M NPPB, an 
anion-transport  inhibitor,  effectively blocked gcl  (Fig.  6),  but  increased the  rate  of ~,  12 
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FIGURE  4.  C1-  conductance  in  response to  osmotic challenge.  The  slope  conductance,  gci, 
plotted  against  time  after  break  in.  Currents  were  elicited  as  described  in  Fig.  3;  gcJ  was 
determined from a  linear least-squares fit to the current-voltage relation at potentials between 
-35  and  -55  mV. The maximal rate of increase ofgcl was determined by fitting a  line to the 
maximum slope ofga  vs time plot (e.g.,  straight line in B). 
TABLE  I 
Induction of gcl 
Cell Type  Stimulus  gcl  dgcl/dt  Ra  Cm  gcl/Cm 
NIH-3T3 
NIH-3T3 
NIH-3T3/MDR 
NIH-3T3/MDR 
8226 
8226/Oox40 
Hypertomc internal 
Hypotomc external 
Hypertonic internal 
Hypotomc external 
Hypertonic internal 
Hypertomc internal 
nS  nS/s  M12  pF  nS/pF 
33.8+9.1  0.24-0.11  3.8  •  0.8  29.7-+6.3  1.30+ 0.31 
(n =  5)  (n =  6)  (n =  5)  (n =  5)  (n =  5) 
25.2  --  12.3  0.31  -+ 0.30  5.3  -  3.8  29.7  •  6.0  0.83 •  0.35 
(n =8)  (n=8)  (n=8)  (n =8)  (n =8) 
39.4 •  16.4  0.43 +- 0.13  4.7  -+  1.1  39.3  •  9.2  0.99 •  0.33 
(n=6)  (n=6)  (n=6)  (n=6)  (n=6) 
29.9 -  10.9  0.52  •  0.32  4.4 --. 4.2  36.6  •  5.9  0.82  •  0.30 
(n =  23)  (n =  25)  (n =  22)  (n =  22)  (n =  22) 
6.1  +- 3.8  0.03 +- 0.02  4.9 --.  1.0  21.5  -'- 4.9  0.31  -'- 0.20 
(n =  12)  (n =  12)  (n =  9)  (n =  9)  (n =  9) 
7.7  •  5.3  0.03 •  0.02  4.6 •  1.0  21.2  •  7.2  0.37  ~  0.22 
(n =  10)  (n =  8)  (n =  7)  (n =  7)  (n =  7) 
Cell  swelling  was induced by addition  of 100  mM  sucrose to the pipette  solution or by exchange of the 
bathing solution with 67% Ringer. gc] and dgcl/dt were calculated from the slope of the I-V relation near the 
reversal potential for currents elicited  by ramp stimuli as in Fig. 5. Ra and Cm were calculated as described in 
the  Methods. When gcl was normalized for the  size of the cell  (gcl/Cm), there was no significance  in the 
magnitude or rate of induction ofgc] in either drug-sensitive and -resistant cell pair. Data are presented as 
the mean -+ SD. EHRING  ET AL.  MDR and Chloride Channels  1141 
R123  transport  (see  Fig.  13  below).  The  chloride-channel  blocker,  DIDS  (50  ~M) 
blocked  gel  in  both  NIH-3T3  control  and  NIH-3T3/MDR  cells  (Figs.  6  and  7), 
whereas doses as high as 1 mM had little effect on R123 transport (see Fig.  13 below). 
All  three  compounds  had  similar effects on gr  in  8226  myeloma and  8226/Dox40 
cells  (data  not  shown).  Thus,  our  results  demonstrate  that  verapamil blocks  drug 
transport at doses that have no effect on gel. Conversely, DIDS blocks the current at 
doses which  do  not  affect drug  transport.  Finally,  NPPB  can  block the  current  at 
doses that increase drug transport. 
A  8226  B  8226 Dox40 
C  m = 15 pF  Cm = 22 pF 
~0pA 
NIH-3T3  25 ms  D  NIH-3T3 MDR 
C  m = 34 pF  C  m = 40 pF 
1000 pA 
l__ 
2000 ms 
NIH-3T3 MDR 
l 
FIGURE 5.  CI- currents elicited by a series of 200-ms voltage pulses from -100 to + 100 mY. 
Internal solution:  hyperosmotic Cs aspartate; external solution:  mammalian Ringer.  Currents 
were neither leak-subtracted nor normalized for cell size. For all cells, Icl had similar magnitude 
and kinetics.  The larger currents in 8226/Dox40 and NIH-3T3/MDR cells (B and D) can be 
accounted for by cell size, as indicated by measured Cm values (see Table I). 200-ms pulses over 
this voltage range resulted in little or no channel closing. (E) During prolonged depolarizations 
up to +120 mV, slow channel closing may be seen for voltage pulses > +60 inV. 
According to the dual-function model for P-glycoprotein, substrate binding to the 
drug  transporter  should  inhibit  drug  transport  (Gill  et  al.,  1992).  We  tested  this 
prediction during whole-cell patch clamp experiments by dialyzing the cell with 200 
I~M doxorubicin before exposure to hypoosmotic external solution. Since doxornbicin 
is fluorescent, we confirmed its intracellular dialysis by video imaging: half times for 
dialysis ranged from 150-300  s depending on Ra. When fluorescence had reached a 
steady state, we exchanged the bath solution with 70% Ringer, effecting cell swelling 1142  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  .  VOLUME  104  ￿9 1994 
and the subsequent characteristic induction of outwardly rectifying C1- current (Fig. 
8).  In  17  similar experiments, neither the amplitude of gcl nor its rate of induction 
after hypoosmotic swelling was altered by 200 ~M doxorubicin or 250  ~M vincristine 
in the pipette solution (Fig. 9  and Table II). 
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FIGURE 6.  Pharmacological effects on volume-activated gcv Voltage ramps were used to test 
the effects of verapamil (A,B), NPPB  (C,D) and  DIDS (E,F) on gc~ in  NIH-3T3  (A,C,E) and 
NIH-3T3/MDR (B,D,E) cells. In each case, traces are labeled as  1 (control), 2  (drug), and  3 
(wash out). Verapamil, at a dose (10 IzM) that completely blocks R123 efflux (see text), did not 
affect gcl. Conversely, 50 I~M NPPB and DIDS significantly reduced gcl in both drug-sensitive 
and drug-resistant cells. DIDS had no effect on R123  transport and NPPB actually increased 
the apparent rate of R123 transport. 
Swelling-activated  Chloride Conductance  in Intact Cells 
Our  initial  observations  using  whole-ceU  recording  provided  no  support  for  the 
hypothesis that P-glycoprotein can function in a  dual manner  (Gill et al.,  1992).  To 
address  this  issue by  an  independent  method,  one  that  could be  applied to  intact 
cells,  we  used  a  video-imaging  fluorescence-quench  assay  to  monitor  membrane 
chloride permeability (see Materials and Methods). Under isoosmotic conditions, there EHRING ET AL.  MDR and Chloride Channels 
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FIGURE 7.  DIDS blocks gcl. Ci- currents were recorded before, during, and after application 
of 50  I~M DIDS. Currents were evoked by 200-ms voltage steps from  -100  to  +100 mV in 
20-mV steps from a  holding potential of -60 mV. Cells were first bathed in normal Ringer, 
then hypoosmotic Ringer to induce go (not shown); the internal solution was isoosmotic CsAsp. 
DIDS was  applied in  hypoosmotic Ringer.  DIDS  blocked the  current  induced  in  NIH-3T3 
control or NIH-3T3/MDR cells in a time- and voltage-dependent manner; block was partially 
reversed by a return to drug-free hypoosmotic Ringer. The degree of block and the recovery 
from block was variable for both the drug-sensitive and -resistant cell lines. Long incubations 
with higher concentrations of DIDS resulted in irreversible block. 
was little gcl activated, and little or no increase of SPQ fluorescence due to I-/NO~ 
exchange. Induction ofgcl by swelling the cells with hypoosmotic extracellular solution 
(67%  of isoosmotic)  led  to  a  rise  in  SPQ  fluorescence  that  could  be  fitted  by  a 
single-exponential  function  (Fig.  10A).  The  rate  of  this  rise  was  a  measure  of 1144  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  104 - 1994 
chloride  conductance  at  the  time  of osmotic  challenge.  Osmotically  induced  cell 
swelling  increased  gcl  in  both  drug-sensitive  and  -resistant  cells  (Fig.  10,  B-E). 
Measurement  of SPQ fluorescence from each individual cell in the microscopic field 
of view enabled  a  stimulus-response relationship  between chloride conductance and 
cell  swelling  to  be  determined  in  separate  experiments  using  drug-sensitive  or 
-resistant  cells.  The  threshold  of the  increase  in  the  SPQ  signal,  and  hence  the 
chloride  conductance,  ranged  from 80  to  70%  of initial  osmolarity.  Although  the 
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FIGURE 8.  Swelling-activated  chloride currents were not affected by doxorubicin. When 200 
tzM doxorubicin was included in the isotonic pipette solution, its entry into the cell could be 
monitored by measuring the fluorescence in a region (ROI) near the center of cell as shown in 
the inset diagram. (A) shows the increase in cellular fluorescence due to the dialysis of the cell 
with doxorubicin. In four experiments of this type, with pipette access resistances ranging from 
2.8 to 9  MI'~, half times for dialysis  ranged from 150  to 300 s. As the fluorescence intensity 
approached a steady state,  the cell was swollen by exposure to hypoosmotic media (70% bar). A 
series  of voltage ramps was applied to the cell before (1), during (2-4), and after (5) exposure 
to hypoosmotic Ringer. (B) The currents elicited by the voltage ramps show a clear induction of 
gcl during exposure to hypoosmotic Ringer (1-4). This current was reversed upon return  to 
isotonic  Ringer  (5). Pipette  solution:  isoosmotic  NMGCI  internal  solution.  Bath  solutions: 
isoosmotic NMGC1 Ringer followed by hypoosmotic NMGCI Ringer. 
maximal amplitude  of swelling-activated  chloride conductance was virtually indistin- 
guishable in both cell types, the threshold for chloride channel opening varied from 
batch to batch,  depending upon the time of cell passage,  and between sensitive  and 
resistant cell lines.  Under identical conditions,  drug-resistant  cells  (NIH-3T3/MDR) 
had  a  somewhat lower  threshold  (Fig.  10 F);  this  difference was  more  pronounced 
early after cell passage. EHRING ET AL. 
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FIGURE  O.  gcl induction is not affected by cell  dialysis with doxorubicin  or vincristine. When 
NIH-3T3  (A)  or  NIH-3T3/MDR  (B)  cells  were  dialyzed  with  isotonic  pipette  solution,  gcl 
remained  at a  very low level for more than 200 s. At this time, dialysis directly monitored from 
the  fluorescence  of  doxorubicin  was  roughly  50%  complete.  Exchanging  isotonic  Ringer 
solution bathing the cells with hypoosmotic Ringer (67% bar) increased gc] with or without drug. 
Chloride  conductance was measured  as described  in  Fig.  4.  Inclusion of 200  IxM doxorubicin 
(C) or 250 IzM vincristine (D) in the pipette solution did not affect the magnitude or the rate of 
increase  of gc]  in  NIH-3T3/MDR  cells.  The  leakage  conductance  of the  cell  in  isoosmotic 
solution was often increased during dialysis with either vincristine or doxorubicin. 
TABLE  II 
Substrates of the Drug-Efflux Pump Do Not Affect gct 
Cell Type  Drug  gcl  dgcl/dt  Ra  Cm  gcI/Cm 
nS  nS/s  Mfl  pF  nS/pF 
3T3/MDR  Control  29.9 +  10.9  0.52 •  0.32  4.4 •  4.2  36.6 •  5.9  0.83 •  0.31 
(n =  23)  (n =  25)  (n =  22)  (n =  22)  (n =  22) 
3T3/MDR  250 I~M vincristine  31.4 •  9.7  0.62 •  0.46  4.0 •  1.4  30.6 •  8.4  1.03 •  0.16 
(n=4)  (n=4)  (n=4)  (n=4)  (n=4) 
3T3/MDR  200 IxM doxorubicin  33.4 •  10.9  0.57 •  0.28  5.3 •  3.7  47.4 •  14.4  0.73 •  0.24 
(n =  6)  (n =  6)  (n =  6)  (n =  6)  (n =  6) 
8226/Dox40  Control  7.7 •  5.3  0.03 •  0.02  4.6 •  1.0  21.2 •  7.2  0.50 •  0.34 
(n =  10)  (n =  8)  (n =  7)  (n =  7)  (n =  7) 
8226/Dox40  200 IxM doxorubicin  6.0 •  5.9  0.04 •  0.05  4.7 -  1.1  15.7 •  3.8  0.34 •  0.25 
(n=7)  (n=7)  (n=7)  (n=7)  (n=7) 
Drugs were included in the pipette solution and dialyzed into the cells for 200 s before gcl was induced by 
cell swelling. Data are presented as the mean -+ SD. 1146 
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FIGURE 10.  SPQ-fluorescence assay  of transmembrane chloride conductance in intact cells. 
(A). Changes in SPQ fluorescence in NIH-BTS cells. Initially, the fluorescence was quenched by 
preincubating the cells in extracellular solution containing I-. At first, chloride conductance is 
small,  so  I-/NO~  replacement  does  not  lead  to  an  immediate  increase  in  fluorescence. EHRING ET AL.  MDR and Chloride Channels  1147 
Pharmacology.  The  sensitivity ofgcl to various pharmacological agents in intact 
cells is illustrated in Fig.  1 I. Verapamil, which blocks P-glycoprotein-associated drug 
efflux at submicromolar concentration,  had little or no effect on gcl. Among several 
agents  tested,  the  most  effective  blocker  was  tamoxifen;  10  p,M  completely  and 
irreversibly blocked  the  conductance  after  ~  100  s.  DIDS  and  NPPB  quickly  and 
reversibly blocked the conductance  at concentrations  of 1 mM  and  30  ~M,  respec- 
tively. Our  SPQ-quench  measurements  of go  corroborate  the  patch  clamp data;  in 
comparison with R123  efflux measurements  (below), both methods of measuring gcl 
demonstrate  that  the  swelling-activated chloride  channel  and  the  P-glycoprotein- 
mediated drug efflux pump  have very different pharmacological sensitivities. 
R123 Efftux in Drug-sensitive  and -resistant  Cells 
The  first  section  of  Results  used  steady  state  levels  of  R123  accumulation  to 
document  P-glycoprotein levels  in  drug-resistant  cell  lines.  Here,  we  describe  the 
rates of R123 efflux measured from the decrease in R123 fluorescence after removing 
extracellular  dye.  The  time  course  demonstrates  that  the  rate  of R123  efflux  in 
8226/Dox40  cells is nearly  100  times higher than  in the drug-sensitive counterpart, 
8226  (Fig.  12). Verapamil is a  highly effective inhibitor of P-glycoprotein-mediated 
multidrug resistance, and blocked P-glycoprotein-mediated R123  efflux (Fig.  12 A). 
In  the  control  cells,  verapamil  had  no  effect  (Fig.  12B).  To  study  the  dose 
dependence of verapamil block, we measured  the decrease in R123  fluorescence in 
the presence  of varying concentrations  of verapamil (Fig.  12 C).  The concentration 
dependence was fitted with the equation: 
1/T =  (1/To) *  1/(1  +  [ver]/Kd) +  1/Tv, 
where T is a time constant for the decrease in R123 fluorescence, To the time constant 
in  the  absence  of verapamil,  Tv  the  time  constant  at  saturating  concentrations  of 
verapamil,  [ver]  the  verapamil  concentration,  and  Kd  the  binding  constant  for 
Hypoosmotic challenge (67%) activates go leading to an increase in the rate of SPQ fluorescence 
rise.  NO~/1-  pulsing with  a  period  of  100/100  s.  Quenching  and  unquenching  of SPQ 
fluorescence was fitted with a  single exponential function. There was also a  slow, irreversible 
decrease in SPQ fluorescence (indicated by arrows in A ), apparently due to leak of SPQ from 
the cell, which was further facilitated by osmotic challenge. The time constant of this leak was 
~ 600 s and was taken into account during prolonged experiments. During the first 100 s after 
solution exchange, the time dependence of SPQ fluorescence was close to linear and the simple 
ratio of maximal fluorescence over initial fluorescence (AF/Fo) could be used as a measure of 
membrane  chloride conductance.  Therefore,  we  used  short  pulses  (50/50  s)  of solution  to 
measure go. Arrows indicate upper  limits of SPQ fluorescence that would be reached  after 
NO~- application. Fluorescence measurements for three cells are shown in each of panels (B-E). 
The bar indicates hypoosmotic/isoosmotic Ringer exchange. Reducing osmolarity to 80% (B,D) 
caused  a  small  increase  of go  in  NIH-3T3  control  cells  and  a  slightly larger  increase  in 
NIH-3T3 MDR cells. 60% Ringer (C,E) induces a larger change in go in NIH-3T3 control cells 
and in NIH-3T3  MDR cells. (F) Stimulus-response of C1-  conductance vs osmolarity. Values 
represent mean  -SD for go for NIH-3T3 control (n =  37) and NIH-3T3 MDR (n = 42) cells. 
Thus, drug-resistant and -sensitive cells had the same maximal gcl, but drug-resistant cells had 
a slightly higher sensitivity to osmotic challenge. 1148  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  104.  1994 
verapamil.  The  /Ca  for blocking  R123  efflux  from  8226/Dox40  cells  was  0.54  ~M. 
Similar  results  were  obtained  in  NIH-3T3/MDR  cells  (/Ca of 0.39  ~M,  data  not 
shown). 
Cl--channel  blockers do  not  inhibit  R123  efftux.  Patch  clamp  studies  presented 
above  show  that  swelling-activated  chloride  channels  in  drug-resistant  and  drug- 
sensitive  3T3  fibroblasts  and  8226  myeloma cells  are  blocked by DIDS,  tamoxifen, 
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FIGURE 11.  Effects  of verapa- 
rail,  tamoxifen,  DIDS,  and 
NPPB on gcl in NIH-3T3 MDR 
cells  superfused  with  60% 
Ringer.  Panels  show  averaged 
SPQ  fluorescence  signals  for 
27-42  cells.  Top shows  a  con- 
trol  response.  Verapamil  (100 
~M)  had  no  significant  effect 
on  gel. Tamoxifen  (100  p,M) 
slowly  (tl/2 =  100  s)  and  irre- 
versibly  blocked  gcv  DIDS  (1 
raM)  and  NPPB  (30  ~M) 
caused a rapid (tl/2  <  10  S) and 
reversible  reduction  in  gcv 
DIDS fluorescence has  consid- 
erable  spectral  overlap  with 
SPQ;  to compensate  for varia- 
tions  in  background  fluores- 
cence  we  subtracted  back- 
ground fluorescence measured 
in regions of interest positioned 
near  each  individual  cell  from 
the cells' fluorescence. 
and NPPB. Inhibition was confirmed in intact cells using the SPQ fluorescence assay 
(Fig.  11). None of these blockers inhibited P-glycoprotein-mediated R123 emux (Fig. 
I3, A-C). These results  demonstrate  that pumping can occur normally even though 
CI- channel function is completely blocked. 
Mitochondrial  uncouplers  accelerate  R123  esflux. The  chloride-channel  blocker, 
NPPB, markedly increased the rate of R123 efflux in drug-resistant cells (Fig.  13 D). EHRINO ET AL.  MDR and Chloride  Channels  1149 
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Rhodamine-123  efflux differs between  8226/Dox40  (A)  and  8226  myeloma cells 
(B). Cells were loaded by incubation with 5 I~M R123 and 5 I~M verapamil (ver) for 20 min. The 
cells were washed with Ringer containing the indicated concentration  of verapamil at 0  s,  and 
were washed with drug-free Ringer at 200  s.  Fluorescence intensity was used  as a  measure  of 
intracellular  R123  concentration.  Each  panel  is an  average  of the  traces  from  the  indicated 
number of cells. (A) The rate of R123 efflux was determined by fitting exponential functions to 
the decrease of fluorescence with time. In the absence of verapamil (A, top), the trace was fitted 
with a  single-exponential function.  For the remaining panels,  the trace was  divided into two 
parts  (from 0  to 200  s in the presence of verapamil; and from 200 s to 850 s after washout of 
verapamil), and each part was separately fitted by a  single exponential function. This analysis 
gave the  rate  of efflux  of R123  in  presence  and  absence  of verapamil.  Verapamil  caused  a 
dose-dependent  decrease  in  the rate  of R123  efflux. After washout  of verapamil,  the rate  of 
R123  efflux did not differ significantly from control. (B) In control,  8226 cells, the decline of 
R123 fluorescence is extremely slow and unaffected by verapamil added either early or late in 
the experiment. (C) The rate of R123 efflux is plotted against the log of the dose of verapamil 
for both cell types. 1150  THE JOURNAL Or  GENERAL PHYSIOLOGY  '  VOLUME 104 ￿9 1994 
This  result was  initially  surprising,  but can be  explained  by the  ability  of NPPB  to 
increase the cytoplasmic concentration of R123 by redistributing  the substrate inside 
the cells. R123 is positively charged and accumulates primarily in mitochondria (Fig. 
14);  the  cytoplasmic concentration  is  much lower because  the  mitochondrial  mem- 
brane  potential  allows the positively charged dye to be sequestered  (Neyfakh,  1988; 
Lampidis  et  al.,  1989; Weaver et al.,  1991).  It has  been  shown  that  NPPB,  besides 
being a  CI- channel blocker,  uncouples oxidative  phosphorylation in mitochondria 
and  increases  the  proton  permeability  of the  plasma  membrane  in  phagocytic cells 
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F]GURE 13.  Chloride-channel 
blockers  have  differing  effects 
on R123 efflux.  Time course of 
R123  efflux  from  NIH-3T3 
MDR cells was measured as de- 
scribed in Fig.  12. The addition 
of DIDS  (A)  or  tamoxifen  (B) 
had no significant effect on the 
rate  of R123  efflux.  NPPB  (C) 
and  CCCP (D)  significantly  in- 
creased the rate of R123 efflux. 
Traces  shown  are  the  average 
of 27-39  cells.  Rates  of efflux 
were  determined  by  the  fit  of 
two  individual  single-exponen- 
tial  functions  before  and  after 
drug  addition.  Neither  CCCP 
nor NPPB increased the rate of 
R123  eMux  in  drug-sensitive 
control  NIH-3T3  and  8226 
cells  (data  not  shown).  More- 
over, neither CCCP nor NPPB 
overcame the blocking effect of 
verapamil  on  R123  efflux  in 
drug-resistant  cells  (data  not 
shown). 
(Lukacs,  Nanda,  Rotstein,  and  Grinstein,  1991).  An uncoupler would  decrease  the 
electrochemical  gradient  across the  mitochondrial  membrane,  causing R123  release 
to  the  cytoplasm,  thus  making  the  dye  more  accessible  to  the  P-glycoprotein- 
associated pump in the plasma membrane. 
We confirmed the uncoupling action of NPPB by demonstrating that NPPB causes 
changes in the pattern  of R123 fluorescence in NIH-3T3 cells. Confocal microscopy 
images taken before adding NPPB revealed R123 fluorescence within mitochondria, 
with little or no nuclear staining; after adding NPPB, the fluorescence became evenly EHRING ET AL.  MDR and Chloride Channels  1151 
FIGURE 14.  NPPB releases R123 from mitochondria. (A) Confocal images of NIH-3T3/MDR 
cells loaded with R123 in the presence of 10 ~M verapamil display bright, punctate staining of 
mitochondria.  (B)  Images  taken  100  s  after  adding  NPPB  show  more  diffuse  staining with 
R123. The integral of the fluorescence intensity over each individual cell was not significantly 
different before or after addition of NPPB. Similar results were obtained with NIH-3T3 control 
cells and with both cell lines using CCCP instead of NPPB (data not shown). 
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FIGURE 15.  Cell swelling does 
not  affect  R123  efflux.  Cells 
were  swollen by applying 60% 
Ringer, causing a large increase 
in gc~ (see Fig.  10).  R123 efflux 
was  measured  as  described  in 
Fig. 12. Rates of efflux were not 
significantly different in control 
experiments  (A)  and  when 
NIH-3T3 MDR cells were swol- 
len with 60% Ringer (B). Traces 
in A  and B  are  averages  from 
37 and 32 cells, respectively. 1152  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  104"  1994 
distributed throughout the cytoplasm, with considerable nuclear staining (Fig. 14). As 
expected from results with NPPB, extracellular application of another protonophore, 
carbonyl cyanide m-chlorophenylhydrazone (CCCP)  causes  redistribution  of mito- 
chondrial R123,  along with a  rapid collapse  of the  mitochondrial electrochemical 
gradient. In cells expressing P-glycoprotein, CCCP causes a dramatic increase in the 
rate  of R123  efflux (Fig.  14 E). We conclude that the normal rate  of R123  efflux 
observed  in  the  absence  of  uncoupler  is  limited  by  the  rate  of  release  from 
mitochondria, 
R123  effiux  is  not  blocked by  cell swelling.  It  has  been  proposed  that  the 
swelling-activated  chloride  conductance  is  mediated  by  P-glycoprotein,  with  P- 
glycoprotein  functioning  either  as  a  chloride  channel  during  cell  swelling  or  a 
drug-efflux pump  (Valverde et al.,  1992).  This model implies that activation of gel 
would impair drug  pumping by drug-resistant cells.  However,  the  measured time 
constants for R 123 efflux were 314 -+ 19 s (n =  37) in isoosmotic Ringer and 328 +- 23 
s  (n =  32)  in  60%  Ringer  in  NIH-3T3/MDR  cells  (Fig.  15). Similar results were 
obtained in three additional experiments on 3T3/MDR cells and two experiments on 
8226/Dox40 cells. Thus, R123 extrusion was not significantly different in cells swollen 
by hyposmotic extracellular solution. 
DISCUSSION 
In  this  study,  we  examined  the  hypothesis  that  P-glycoprotein  forms  swelling- 
activated  CI-  channels.  Our  principal  aim  was  to  determine  if  P-glycoprotein 
expression affected the magnitude or biophysical properties of gcl in drug-sensitive 
and -resistant cells. Indirect immunofluorescence and confocal microscopy demon- 
strated that membrane  localization of P-glycoprotein accompanied the  multidrug- 
resistant  phenotype.  Video  imaging  showed  that  unidirectional  R123  efflux,  a 
measure of P-glycoprotein function, was significantly higher in drug-resistant cells. 
Using two independent and complementary assays of gcl, whole-ceU current record- 
ing and SPQ-fluorescence quench, we  showed that cell swelling induced the  same 
level of chloride conductance in the drug-sensitive and -resistant cells. In addition, 
comparing the  dose  dependence  for inhibition of gcl  and  R123  transport  clearly 
dissociates the pharmacology of block for drug transport and chloride conductance. 
Furthermore, we tested two predictions of a  model proposing  that P-glycoprotein 
acts exclusively as a transport pump or an ion channel (Gill et al., 1992).  Contrary to 
the model's predictions, we find that induction of swelling-activated chloride chan- 
nels  does  not inhibit R123  effiux, and  R123  efflux does  not inhibit gcl  in  drug- 
resistant cells. Thus, these two processes appear to occur independently. 
Biophysical Properties of gcl in Drug-sensitive  and -resistant Cells 
In  drug~sensitive  and  -resistant  NIH-3T3  fibroblasts  or  8226  myeloma cells,  Icl 
exhibited moderate outward rectification in symmetrical chloride solutions, slow and 
somewhat variable closing kinetics during long pulses to voltages positive to +60 mV, 
and similar Kd values for block by DIDS, NPPB, and tamoxifen. The rectification ratio 
of Icl  and  the  relative  permeabilities  of chloride,  aspartate,  and  glutamate were 
identical in all four cell lines. The induction of gcl in response to cell dialysis with EHRING ET AL.  MDR and Chloride Channels  1153 
hyperosmotic pipette solution, or bath exchange with hypoosmotic Ringer, occurred 
over  the  same  time  course  for  both  drug-sensitive  and  -resistant  cells.  During 
whole-cell recording, the maximum gcl varied with the size of the cell, but not with 
the level of expression of P-glycoprotein. Thus, electrophysiological measurements 
do not distinguish between gcl in these cells. 
Swelling-activated CI- channels have now been observed in a wide variety of cell 
types (reviewed in Cahalan and Lewis,  1994).  Indeed, in our experience it has been 
difficult to  find  a  cell  type  in  which gcl  does  not  activate  when  swollen  during 
whole-cell recording  by an  imposed  osmotic  gradient.  The  control  drug-sensitive 
NIH-3T3,  myeloma, and MCF-7 cell lines lacking P-glycoprotein are no exception. 
Based on biophysical characteristics, swelling-activated CI- channels may be divided 
into two classes: a  small conductance channel that closes very slowly during strong 
depolarization, and a  larger conductance channel that closes more rapidly during 
strong depolarization.  Lymphocytes, chromaffin cells, neuroblastoma cells, neutro- 
phils, fibroblasts, osteoclasts, cardiac cells, endothelial cells and Xenopus oocytes have 
channels  that  are  activated  by  swelling,  show  moderate  outward  rectification  in 
symmetrical chloride solutions, and lack voltage-dependent gating (Estacion,  1991; 
Tseng,  1992;  Falke and Misler,  1989;  Lewis  et al.,  1993;  Doroshenko and  Neher, 
1992;  Pollard, 1993;  Stoddard, Steinbach, and Simchowitz, 1993;  Zhang, Rasmusson, 
Hall, and Lieberman,  1993;  Kelly, Dixon, and Sims,  1994;  Nilius, Oike, Zahradnik, 
and Droogmans,  1994; Ackerman, Wickman, and Clapham,  1994).  A single-channel 
conductance of 1-2 pS was estimated by fluctuation analysis of whole-cell currents in 
T lymphocytes, neutrophils and endothelial cells (Cahalan and Lewis, 1988;  Lewis et 
al., 1993; Stoddard et al., 1993;  Nilius et al., 1994).  In epithelial cells from the airway 
and trachea, intestinal or colon cells, and Ehrlich ascites tumor cells, single-channel 
conductances of 28-75  pS  have been  measured  (Worrell,  Butt,  Cliff, and  Frizzell, 
1989;  Solc and Wine,  1991;  Kubo and  Okada,  1992;  Christensen and  Hoffmann, 
1992).  Several epithelial cell lines have volume-sensitive CI-  channels that close at 
voltages positive to  +80 mV 0gorrell et al.,  1989;  Solc and Wine,  1991;  Kubo and 
Okada,  1992;  Rasola,  Galietta,  Gruenert,  and  Romeo,  1992).  The  time course  of 
closing appears  to  be  one  of the  most variable  properties  of these  channels.  For 
example,  in T84 cells, closing time constants range from several hundred ms  (Solc 
and Wine,  1991)  to several seconds (Worrell et al.,  1989).  Slow channel closing was 
observed with variable kinetics in our experiments on NIH-3T3 cells (e.g., Fig. 5 E). 
The widespread expression of swelling-activated chloride currents and the variability 
in their biophysical properties (single-channel conductance, permeability ratios, and 
closing) suggest that these channels comprise a large and complex family of proteins 
or have mutiple regulatory mechanisms. 
To this point, swelling-activated chloride conductances have mainly been studied 
using the whole-cell patch  clamp  configuration after induction of cell  swelling by 
an applied  transmembrane osmotic gradient. Cell swelling can be  initiated during 
whole-cell recording either by increasing the osmolarity of the pipette solution or by 
lowering the osmolarity of the extracellular solution. In either case,  the amount of 
cell  swelling  is  difficult to  control,  because  it  depends  not  only on  the  osmotic 
gradient (as in intact cells), but also on the size of the pipette opening, on membrane 
permeability to water,  and on mechanical properties  of the cell membrane. These 1154  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9  VOLUME  104  ￿9  1994 
variables have been modeled recently (Ross,  Garber,  and Cahalan,  1994).  Because 
the cell interior under whole-cell recording is  dialyzed by the infinite reservoir of 
solution in the patch pipette, the model predicts the ultimate disruption of the cell 
membrane due to uncontrolled swelling if a high enough osmotic gradient is applied. 
This prediction has been confirmed experimentally (Ross  et al.,  1994).  Because of 
problems in controlling cell swelling during whole-cell recording, it is important to 
control for access resistance when comparing gcl obtained by patch clamp  experi- 
ments on different cell lines. By monitoring SPQ fluorescence with video imaging, we 
developed a  technique to assay gel in intact cells under controlled conditions. The 
SPQ-quench experiments corroborated our patch clamp data on the time course and 
pharmacological sensitivity of gc~, and permitted a fairly accurate assessment of the 
threshold for channel activation by cell swelling. 
Does P-Glycoprotein Form a  Chloride  Channel? 
The  model  of  P-glycoprotein  as  a  swelling-activated  C1-  channel  rests  on  the 
observation  that  transfection of P-glycoprotein cDNA  into  drug-sensitive  cells  re- 
sulted in the expression of swelling-activated C1-  channels (Valverde et al.,  1992). 
This observation was supported by experiments showing overlap in the pharmaco- 
logical inhibition of drug transport. 
gct  is  not  correlated  with  P-glycoprotein  expression.  During  our  patch  clamp 
experiments, osmotic challenge with either hypoosmotic external solution or hyperos- 
motic internal solution resulted in cell swelling, which was invariably followed by the 
induction ofgcl in both control or drug-resistant cell lines. We found that cell swelling 
induced gcl  of similar magnitudes,  rates  of induction and  biophysical properties, 
irrespective of P-glycoprotein expression or drug-transport activity (Figs. 3-5, Table 
I). After we observed large chloride conductances in the control NIH-3T3 fibroblasts, 
which were not reported by Valverde et al. (1992), we first ruled out the possibility of 
anomalous P-glycoprotein expression or drug-efflux activity in our cells. Direct assays 
of P-glycoprotein content and functional assays showed that our control cells do not 
express measurable amounts of P-glycoprotein. FACS analysis and confocal micros- 
copy  showed  (Fig.  1)  that  P-glycoprotein was  abundantly expressed  in  the  drug- 
resistant cells (8226/Dox40 and NIH-3T3/MDR) but not in drug-sensitive cells (8226 
myeloma and NIH-3T3 control). The transport function of P-glycoprotein in these 
cells was confirmed using R 123-accumulation assays (Fig. 3). R 123 accumulation was 
blocked by verapamil, a known inhibitor of P-glycoprotein-mediated transport. Thus, 
drug resistance was  correlated with expression  of P-glycoprotein in  our cell lines. 
These results were confirmed and extended by measuring efflux rates for R123 (Figs. 
12,  13,  15); rates were  >60-fold faster in 8226/Dox40  than in 8226 myeloma cells, 
and  > 100-fold faster in 3T3/MDR cells compared with NIH-3T3  control cells.  In 
control cells, verapamil had no effect on the rate of R123 loss, indicating undetect- 
able  functional expression  of R123  (Fig.  12). Weaver  and  co-workers  (1994,  and 
personal communication) found more than 55,000 binding sites for the P-glycopro- 
tein-specific monoclonal antibody, MRK-16, on NIH-3T3/MDR cells and fewer than 
400 antibody binding sites on NIH-3T3 control cells (the limits of resolution of the 
measurement).  In  comparison,  how  many  chloride  channels  are  present?  The EHRING ET ~.  MDR and Chloride Channels  1155 
single-channel conductance has  not been determined in  these cells.  If we  take  an 
estimate  from  noise  analysis  of  2  pS  for  similar,  outwardly  rectifying,  swelling- 
activated  CI-  channels  in  lymphocytes  (Cahalan  and  Lewis,  1994),  the  average 
number  of channels  per  cell  would  be  14,000  and  16,000  channels  per  cell  in 
drug-sensitive and -resistant NIH-3T3 cells, respectively. Thus, there appears to be 
no correspondence between  the  number  of chloride channels  and  the  number  of 
P-glycoprotein molecules per cell. Regardless of the exact numbers, the near equality 
of gel combined with the disparity in P-glycoprotein expression strongly argues that 
drug effiux and chloride channel functions are mediated by different proteins. 
Activation of go  consistently occurred with  several combinations  of pipette  and 
bath  solutions,  whenever the  cells were  swollen  and  access  resistance  maintained. 
Most of our experiments were performed with solutions containing asymmetric CI- 
concentrations,  providing a  negative  reversal potential to distinguish  CI-  currents 
from nonspecific leak currents;  solutions  containing  symmetrical CI-  were  equally 
effective. Using NIH-3T3 cells obtained from the same source, and duplicating the 
solutions  and  voltage-clamp  protocols  used  in  previous  studies  (Gill  et  al.,  1992; 
Valverde et al.,  1992; Diaz, Valverde, Higgins, Rucareanu, and Sepulveda, 1993), we 
found equivalent gcl in both control and MDR-transfected  cells. We also varied the 
stimulus for cell swelling by using Ringer solutions which were 90,  80,  70,  or 67% 
hyposmotic.  In  all  cases,  gcl  induction  occurred  to  the  same  extent  in  both 
drug-sensitive and drug-resistant cell lines varying in P-glycoprotein expression by at 
least two orders of magnitude. 
Our SPQ-quench measurements of swelling-activated gcl in intact cells suggest that 
P-glycoprotein expressing cells  may be  somewhat  more  sensitive  to  the  effects of 
osmotic gradients than control cells (Fig.  10). We have shown previously (Ross et al., 
1994) that the extent of cell swelling and gcl induction during whole-cell recording 
depends critically on several variables including pipette access resistance,  as well as 
osmolyte concentration. We routinely monitored access resistance during whole-cell 
recording,  and  typically obtained values less than 5  M~.  The use of large osmotic 
gradients (33% difference between intracellular and extracellular osmolarity) ensured 
maximal  swelling  and  induction  of gcl.  In  some  patch  clamp  experiments,  we 
observed  spontaneous  increases  in  access  resistance,  accompanied  by  artifactual 
decreases  in gcl  (data  not  shown).  In  general,  gcl  values  reported  previously  on 
NIH-3T3/MDR  cells  were  severalfold  smaller  than  the  currents  we  observed  in 
control or transfected NIH-3T3 cells. The differences in experimental outcomes from 
previous  work  (Valverde  et  al.,  1992)  might  be  explained  by  the  extent  of cell 
swelling, the threshold for activation ofgcl, the access resistance, or all three factors 
together. The opening of CI- channels may involve a cascade of events following cell 
swelling.  P-glycoprotein expression may lead  to  pleiotropic changes  that  result  in 
upregulation of a component in the pathway that links the cell's volume increase to 
channel activation. We have observed that control NIH-3T3 cells tend to be flatter 
than transfected NIH-3T3/MDR cells (data not shown),  possibly making low access 
resistance more difficult to achieve, or reducing the degree of stretch in the surface 
membrane for a given increase in volume. An indirect role for P-glycoprotein might 
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reduced  go  (Valverde  et  al.,  1992).  Recently,  Altenberg  et  al.,  (1994b)  reported 
finding volume-sensitive Cl-  channels in human  breast cancer cells (BC 19/3)  after 
transfection  with  P-glycoprotein  cDNA,  but  not  in  the  parental  cells  (MCF-7). 
However,  using  our  standard  protocol,  we  found  large  outwardly  rectifying  Cl- 
conductances  in  MCF-7  cells  following cell  swelling  induced by  hypotonic Ringer 
(data  not shown).  We also confirmed that  the  MCF-7  cells  showed no evidence of 
P-glycoprotein expression, but have not pursued this comparison further (data not 
shown),  gcl  magnitudes  reported  by  Altenberg  and  colleagues  (1994a, b)  in  the 
drug-resistant  BC19/3  cells were smaller than we observed in control MCF-7  cells, 
again  suggesting  suboptimal  activation  of gcl.  We  conclude  that  expression  of 
P-glycoprotein  does  not  alter gcb  with  the  caveat  that  the  cells  may  have  to  be 
optimally swollen to reveal similar levels of go. 
Drug eff~ux and gct are pharmacologically separable. A second line of evidence used 
previously to link gcl to P-glycoprotein was the report that some agents block both 
drug efflux and gcl (Valverde et al.,  1992; Diaz et al.,  1993; Nilius et al.,  1994). We 
have  compared  the  ability  of several  agents  to  inhibit  R123  transport  and  gcl. 
Valverde  and  colleagues  (1992)  reported  that  100  ~M  verapamil blocked gcl  and 
drug  transport  in  NIH-3T3  cells  transfected with  P-glycoprotein; this was  seen  as 
evidence that  P-glycoprotein forms both chloride channels  and the  drug transport 
pump.  In 3T3/MDR cells, we determined a Kd of 0.39  ~M  for verapamil block of 
unidirectional  R123  efflux, while  100  ~M  verapamil had  little or no  effect on gcl 
determined by whole-cell recording or by SPQ imaging in NIH-3T3/MDR cells (Figs. 
6,  11,  12). We also found agents that blocked gcb but not R123 efltux. For example, 
DIDS,  tamoxifen, and NPPB blocked gcl at doses which did not block R123 efflux. 
Certain  organic blockers of K +,  Na +,  and  Ca  2+,  but  not  CI-,  channels  have been 
shown to inhibit drug transport in mouse lymphoma cells, most likely not by virtue of 
channel block, but by interacting directly with P-glycoprotein (Weaver et al.,  1993). 
Thus, there appears to be a clear dissociation between the pharmacology ofgcl and 
the drug-efflux pump. 
Not only was NPPB ineffective in blocking R123 efflux, but the rate of R123 efflux 
actually increased in the presence of NPPB. We propose that  the enhanced  efflux 
rate is due to greater access of the dye substrate to the P-glycoprotein efflux pump 
after collapse of the mitochondrial membrane potential. Using confocal microscopy, 
we determined that the cytoplasmic concentration of R123 increases after exposure 
to  NPPB,  an  effect that  is  most  likely related  to  its  known  protonophore activity 
(Lukacs  et  al.,  1991),  because  the  more  effective  protonophore  CCCP  further 
enhances the R123 efflux rate. CCCP also increases the cytoplasmic concentration of 
R123,  but  does not  significantly affect R123  efflux in  control NIH-3T3  cells. The 
results with mitochondrial uncouplers suggest that R123 eittux is limited by substrate 
access to P-glycoprotein in the surface membrane, and is rate limited by release from 
mitochondria.  We  checked  the  ability  of verapamil  to  inhibit  R123  efflux  from 
NIH-3T3/MDR cells in the presence or absence of CCCP, and obtained Kd values of 
0.26 I~M and 0.39 ~M, respectively (data not shown). The close agreement of these 
Kd values  confirms  that  verapamil  inhibits  substrate  efflux by affecting the  pump 
rather than substrate availability. EHRING ET AL.  MDR and Chloride Channels  1157 
Drug Efftux and gcl Are Not Mutually Exclusive 
Gill et al. (1992) proposed a specific model in which a molecule of P-glycoprotein can 
function either as a pump or a channel, but not as both at the same time. According 
to this pump/channel model, substrate binding to P-glycoprotein drives the molecule 
into  the  pump  conformation  and  channel  activation  is  inhibited.  In  support,  they 
reported:  (a)  during  whole-cell  recording,  pipette  addition  of P-glycoprotein  sub- 
strates  inhibited  the  activation  of gcl;  (b)  this  inhibition  could  be  reversed  by 
substituting  nonhydrolyzable  analogues  of ATP  in  the  pipette  solution;  and  (c) 
mutations in P-glycoprotein's nudeotide binding domain also made gcl insensitive to 
inhibition  by  substrates  for  the  pump.  Other  investigators,  using  human  colon 
adenocarcinoma cells (Rasola et al.,  1994)  and breast cancer cells (Altenberg et al., 
1994b;  Han, Altenberg,  and Reuss,  1994),  have had difficulty in reproducing these 
results.  Han  et  al.  (1994)  found  that  of cytotoxic  agents  tested  only  vinblastine 
prevented the induction  of gcl in  BC19/3  cells,  and suggested an indirect effect on 
the CI- channel. We have also been unable to replicate the inhibition of gcl by drug 
substrates  of  P-glycoprotein.  Including  doxorubicin  or  vincristine  in  the  pipette 
solution did not affect gel induction (Figs. 8, 9, Table II); dialysis of doxorubicin was 
confirmed  by monitoring  intracellular  fluorescence.  Thus,  our  results  support  the 
conclusion that gcl is not inhibited by substrate binding to P-glycoprotein. 
A  second  prediction  of the  pump/channel  model  is  that  drug  efflux  should  be 
inhibited if the molecule is driven to function as a  CI- channel during cell swelling. 
Sardini,  Mintenig,  Valverde,  Sepulveda,  Gill,  Hyde,  Higgins,  and  McNaughton 
(1994) reported that cell swelling reduced the rate of doxorubicin efflux by 69% and 
87.2% from NIH-3T3/MDR and S1/I.I  cells, respectively. However, in our experi- 
ments, cell swelling by 67% Ringer had no effect on R123 efflux (Fig.  15);  the same 
stimulus activated gcl maximally in intact cells monitored with the SPQ-quench assay 
(Fig.  10). Similar results were reported by Altenberg et al., (1994b) in BC19/3 cells. In 
conclusion, our experiments are not consistent with the dual-function pump/channel 
hypothesis. 
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